15 Comments
 

Thank you guys for inputting so far.

RC very strong for sure. Interested in hearing more about deal size, as far as I am aware RC v good for volume. IK CVP and PJT dominate biopharma mega deals in US. Interested in hearing about UK/Europe from a HC mega deal perspective too

 
Most Helpful

Quick overview of Europe: 

Evercore's pretty decent - they did AstraZeneca / Alexion + a few other deals, fair mix between sell and buy sides. 

CVP is good for biotech sell sides (in the US), they were also involved in AstraZeneca / Alexion + I think they're trying to replicate that franchise here in Europe. They've been involved in a sell sides here. 

Not sure why you mentioned PJT here - not sure what they do here in Europe. (AbbVie / Allergan doesn't count even though Allergan is "Irish") 

Rothschild and Jefferies are volume shops - predominately PE sell sides. Quick Linkedin search of their profiles and you'd realize they have relatively better PE exits than the aforementioned 3 shops 

From Mergermarket (excluding the BBs, Big4 and MM players, including the generally accepted "EBs" + Jefferies), Target / Acquirer: Europe, Date: 01/01/19 - 14/2/21 (sorted by deal size)

1. Evercore

2. PJT

3. CVP

4. Roths

5. Lazard

6. Jefferies

7. Moelis

Array
 

Wasn't EVR on the buy-side on those deals if I recall? i.e. less fees - how are they number 1?

I think this is very inaccurate...

CVP was on the sell-side of most the mega deals this year. One of their partners, Richard Girling (London partner) is a beast in HC . Also Rothschild and Laz did way better than EVR this year as well.

Dont know much about the rest so can't comment, but EVR as number 1 in London is a joke... Yes they're respected, did a lot better in 2019 than this year, but definitely not number one, they did poor from a fee perspective. 

 

Id et dignissimos quis quaerat est exercitationem quo. Eius quod aut voluptatem.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.8%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • JPMorgan 01 97.7%
  • Goldman Sachs 02 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (44) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (79) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
kanon's picture
kanon
99.0
4
Secyh62's picture
Secyh62
99.0
5
CompBanker's picture
CompBanker
98.9
6
GameTheory's picture
GameTheory
98.9
7
Betsy Massar's picture
Betsy Massar
98.9
8
dosk17's picture
dosk17
98.9
9
DrApeman's picture
DrApeman
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”